MEDIROM Healthcare Technologies Inc. (NYSE:MRM) Short Interest Up 221.3% in October

Market Beat
2025.10.30 22:28
portai
I'm PortAI, I can summarize articles.

MEDIROM Healthcare Technologies Inc. (NYSE:MRM) experienced a significant increase in short interest of 221.3% in October, totaling 868,600 shares as of October 15th, compared to 270,300 shares at the end of September. Approximately 29.4% of the company's shares are currently short sold, with a short-interest ratio of 0.2 days based on an average trading volume of 4,780,000 shares. The stock traded down to $2.07 during midday trading, with a 1-year low of $0.34 and a high of $4.45.

MEDIROM Healthcare Technologies Inc. (NYSE:MRM - Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 868,600 shares, an increase of 221.3% from the September 30th total of 270,300 shares. Based on an average trading volume of 4,780,000 shares, the short-interest ratio is currently 0.2 days. Approximately 29.4% of the shares of the stock are sold short. Approximately 29.4% of the shares of the stock are sold short. Based on an average trading volume of 4,780,000 shares, the short-interest ratio is currently 0.2 days.

MEDIROM Healthcare Technologies Price Performance

Shares of MRM stock traded down $0.55 during midday trading on Wednesday, reaching $2.07. 529,152 shares of the company traded hands, compared to its average volume of 2,095,059. The firm's 50 day simple moving average is $2.02 and its two-hundred day simple moving average is $1.57. MEDIROM Healthcare Technologies has a 1-year low of $0.34 and a 1-year high of $4.45.

MEDIROM Healthcare Technologies Company Profile

(Get Free Report)

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.

Further Reading

  • Five stocks we like better than MEDIROM Healthcare Technologies
  • What to Know About Investing in Penny Stocks
  • Verizon Results Trigger Rebound in High-Yield Stock
  • Business Services Stocks Investing
  • Picks & Shovels: Investing in the Physical Foundation of AI
  • How to Plot Fibonacci Price Inflection Levels
  • Tesla Stock: The Bulls Are Winning…For Now

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MEDIROM Healthcare Technologies Right Now?

Before you consider MEDIROM Healthcare Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MEDIROM Healthcare Technologies wasn't on the list.

While MEDIROM Healthcare Technologies currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.